硬化性-话题@MedSci

#硬化性#

151篇内容 | 3409人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1496291, encodeId=59b1149629123, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识, objectType=article, longId=105315, objectId=f9041053153b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9041053153b, replyNumber=0, likeNumber=31, createdTime=2017-07-13, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9041053153b, moduleTitle=2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9041053153b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496290, encodeId=1f3c1496290e3, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？, objectType=article, longId=98917, objectId=831b9891e07, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=831b9891e07, replyNumber=0, likeNumber=73, createdTime=2017-05-18, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=831b9891e07, moduleTitle=Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=831b9891e07)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496289, encodeId=2609149628970, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！, objectType=article, longId=96707, objectId=e66696e0716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66696e0716, replyNumber=0, likeNumber=0, createdTime=2017-04-23, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66696e0716, moduleTitle=Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66696e0716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496288, encodeId=67a014962882d, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, objectType=article, longId=95067, objectId=4e789506ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e789506ee8, replyNumber=0, likeNumber=57, createdTime=2017-04-09, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e789506ee8, moduleTitle=《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e789506ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496287, encodeId=8a8a149628e6d, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理, objectType=article, longId=93438, objectId=5df19343852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df19343852, replyNumber=0, likeNumber=55, createdTime=2017-03-27, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df19343852, moduleTitle=Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df19343852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496286, encodeId=59d8149628645, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, objectType=article, longId=86894, objectId=d80d86894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d80d86894a4, replyNumber=0, likeNumber=33, createdTime=2017-01-08, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d80d86894a4, moduleTitle=血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d80d86894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496285, encodeId=a4fc1496285e1, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Lancet：硬化性粘液水肿-案例报道, objectType=article, longId=83145, objectId=ca168314595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca168314595, replyNumber=0, likeNumber=60, createdTime=2016-11-27, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca168314595, moduleTitle=Lancet：硬化性粘液水肿-案例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca168314595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496284, encodeId=5bc6149628430, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, objectType=article, longId=81398, objectId=0d7181398c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7181398c2, replyNumber=0, likeNumber=56, createdTime=2016-10-31, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7181398c2, moduleTitle=Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d7181398c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496283, encodeId=51f1149628393, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, objectType=article, longId=79680, objectId=0b07e9680d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b07e9680d3, replyNumber=0, likeNumber=31, createdTime=2016-10-11, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b07e9680d3, moduleTitle=Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b07e9680d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496282, encodeId=76ed1496282a3, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, objectType=article, longId=74240, objectId=2639e42408c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2639e42408c, replyNumber=0, likeNumber=35, createdTime=2016-08-03, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2639e42408c, moduleTitle=2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2639e42408c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496281, encodeId=ed311496281ee, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Hepatology：TIPS治疗非肝硬化性门静脉高压症患者的并发症是安全有效的, objectType=article, longId=72918, objectId=7f57e29184f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f57e29184f, replyNumber=0, likeNumber=78, createdTime=2016-07-17, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f57e29184f, moduleTitle=Hepatology：TIPS治疗非肝硬化性门静脉高压症患者的并发症是安全有效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f57e29184f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496280, encodeId=165f149628020, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, objectType=article, longId=72888, objectId=f5abe2888ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5abe2888ec, replyNumber=0, likeNumber=99, createdTime=2016-07-16, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5abe2888ec, moduleTitle=Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5abe2888ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496279, encodeId=3cad14962e9b9, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加, objectType=article, longId=72000, objectId=8429e200075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8429e200075, replyNumber=0, likeNumber=83, createdTime=2016-07-04, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8429e200075, moduleTitle=Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8429e200075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496278, encodeId=401a14962e816, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力, objectType=article, longId=69365, objectId=3c746936567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c746936567, replyNumber=0, likeNumber=67, createdTime=2016-05-29, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c746936567, moduleTitle=JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c746936567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496277, encodeId=7b8314962e799, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, objectType=article, longId=68990, objectId=3d4a689900d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4a689900d, replyNumber=0, likeNumber=60, createdTime=2016-05-25, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4a689900d, moduleTitle=Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4a689900d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496276, encodeId=505e14962e6ec, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！, objectType=article, longId=68945, objectId=ed2a6894558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed2a6894558, replyNumber=0, likeNumber=59, createdTime=2016-05-25, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed2a6894558, moduleTitle=《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed2a6894558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496275, encodeId=c92c14962e5d7, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=ILC 2016：24-去甲熊脱氧胆酸可改善原发性硬化性胆管炎患者的ALP的水平, objectType=article, longId=66618, objectId=74646661897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74646661897, replyNumber=0, likeNumber=62, createdTime=2016-04-19, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74646661897, moduleTitle=ILC 2016：24-去甲熊脱氧胆酸可改善原发性硬化性胆管炎患者的ALP的水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74646661897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496274, encodeId=69d814962e476, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Neurology：他汀类药物预处理可改善大动脉粥样硬化性卒中结果, objectType=article, longId=65529, objectId=df59655290d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df59655290d, replyNumber=0, likeNumber=55, createdTime=2016-03-27, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df59655290d, moduleTitle=Neurology：他汀类药物预处理可改善大动脉粥样硬化性卒中结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df59655290d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496273, encodeId=103014962e375, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Gut：原发性硬化性胆管炎、溃疡性结肠炎、健康人群的肠道微生物差异, objectType=article, longId=64208, objectId=bac3642087d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bac3642087d, replyNumber=0, likeNumber=23, createdTime=2016-03-07, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bac3642087d, moduleTitle=Gut：原发性硬化性胆管炎、溃疡性结肠炎、健康人群的肠道微生物差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bac3642087d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496272, encodeId=6e2914962e297, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, objectTitle=Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果, objectType=article, longId=61320, objectId=caab613201b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caab613201b, replyNumber=0, likeNumber=63, createdTime=2015-12-31, rootId=0, userName=Smile2683, userId=d8119265602, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caab613201b, moduleTitle=Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=caab613201b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化性

2020-05-29

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识

2017-07-13

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Ann Intern Med：年轻人患动脉粥样硬化性心血管疾病风险升高了？

2017-05-18

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Gut：VAP-1可预测原发性硬化性胆管炎患者临床结局！

2017-04-23

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

《血小板糖蛋白Ⅱb／Ⅲa受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）》盛大发布

2017-04-09

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Diabetes Care：老年糖尿病患者动脉粥样硬化性心血管疾病危险因素的管理

2017-03-27

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

血小板糖蛋白Ⅱb／Ⅲa 受体拮抗剂在冠状动脉粥样硬化性心脏病治疗的中国专家共识（2016）

2017-01-08

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Lancet：硬化性粘液水肿-案例报道

2016-11-27

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Stroke:预防动脉粥样硬化性卒中复发：氯吡格雷联合阿司匹林VS阿司匹林

2016-10-31

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Circulation：量身定做—中国人群动脉粥样硬化性心血管疾病十年风险预测模型问世

2016-10-11

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

2016中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南发布

2016-08-03

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Hepatology：TIPS治疗非肝硬化性门静脉高压症患者的并发症是安全有效的

2016-07-17

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Stroke：氯吡格雷并不能预防急性动脉粥样硬化性卒中后复发缺血性病变

2016-07-16

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Circulation：家族性高胆固醇血症患者动脉粥样硬化性心血管疾病的长期风险增加

2016-07-04

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

JACC：动脉粥样硬化性心血管疾病风险预测新指标：胆固醇流出能力

2016-05-29

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Heart：慢性炎性关节病患者与动脉粥样硬化性心血管疾病的关系

2016-05-25

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

《动脉粥样硬化性心血管疾病管理血胆固醇治疗亚洲共识》即将发布，一起先睹为快！

2016-05-25

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

ILC 2016：24-去甲熊脱氧胆酸可改善原发性硬化性胆管炎患者的ALP的水平

2016-04-19

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Neurology：他汀类药物预处理可改善大动脉粥样硬化性卒中结果

2016-03-27

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Gut：原发性硬化性胆管炎、溃疡性结肠炎、健康人群的肠道微生物差异

2016-03-07

Smile2683 (审核中...)

前往app查看评论内容

#硬化性#

Stroke：阿加曲班治疗动脉粥样硬化性脑卒中没有效果

2015-12-31

科室
- - 订阅+
  - 更多科室
工具
服务